This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Efficacy

Authoring team

The efficacy of orlistat has been demonstrated in various contexts including:

  • simple obesity
  • obese patients with type II diabetes
  • adolescent obesity

Orlistat significantly increases weight loss compared to placebo but its effectiveness is limited by its side-effects. Clinical trials suggest a moderate weight loss compared to placebo - about 2-5 kg over a year.

Reference

  1. Carter R, Mouralidarane A, Ray S, et al. Recent advancements in drug treatment of obesity. Clin Med. 2012 Oct;12(5):456-60

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.